Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

被引：0

作者：

Florent Malard

Myriam Labopin

Christina Cho

Didier Blaise

Esperanza B. Papadopoulos

Jakob Passweg

Richard O’Reilly

Edouard Forcade

Molly Maloy

Liisa Volin

Hugo Castro-Malaspina

Yosr Hicheri

Ann A. Jakubowski

Corentin Orvain

Sergio Giralt

Mohamad Mohty

Arnon Nagler

Miguel-Angel Perales

机构：

[1] AP-HP,Service d’Hématologie Clinique et Thérapie Cellulaire

[2] Hôpital Saint-Antoine,INSERM, Centre de Recherche Saint

[3] Sorbonne Université,Antoine (CRSA)

[4] Memorial Sloan Kettering Cancer Center,Adult Bone Marrow Transplantation Service

[5] Weill Cornell Medical College,Department of Medicine

[6] Institut Paoli Calmettes,Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille

[7] University Hospital,Bone Marrow Transplant Service, Department of Pediatrics

[8] Hematology,Department of Pediatrics

[9] Memorial Sloan Kettering Cancer Center,Stem Cell Transplantation Unit

[10] Weill Cornell Medical College,Département d’Hématologie Clinique

[11] CHU Bordeaux,Service des Maladies du Sang

[12] Hôpital Haut-leveque,Hematology Division

[13] HUCH Comprehensive Cancer Center,Adult Bone Marrow Transplantation Service, Department of Medicine

[14] CHU Lapeyronie,undefined

[15] CHRU,undefined

[16] EBMT Paris Study Office/CEREST-TC,undefined

[17] Chaim Sheba Medical Center,undefined

[18] Memorial Sloan Kettering Cancer Center,undefined

来源：

Journal of Hematology & Oncology | / 11卷

关键词：

Acute myeloid leukemia; T cell depletion; CD34-selected graft; Antithymocyte globulin; Allogeneic hematopoietic cell transplantation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 381 条

[31]

Logan BR(2017)The impact of toxicities on first-year outcomes after ex vivo CD34(+)-selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies Biol Blood Marrow Transplant 23 2004-2011

[32]

Lee SJ(2018)Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 24 133-141

[33]

Waller EK(2018)Impact of toxicity on survival for older adult patients after CD34(+) selected allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant 24 142-149

[34]

Weisdorf DJ(2017)Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis Bone Marrow Transplant 52 1629-1636

[35]

Wingard JR(2017)Co-infections by double-stranded DNA viruses after ex vivo T cell-depleted, CD34(+) selected hematopoietic cell transplantation Biol Blood Marrow Transplant 23 1759-1766

[36]

Cutler CS(2016)Cytomegalovirus infection after CD34(+)-selected hematopoietic cell transplantation Biol Blood Marrow Transplant 22 1480-1486

[37]

Westervelt P(2015)Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 21 959-970

[38]

Woolfrey A(2008)Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation Biol Blood Marrow Transplant 14 913-919

[39]

Couban S(2017)Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial Lancet Oncol 18 1126-1136

[40]

Arai S(2017)Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis Lancet Haematol 4 e183-e191

← 1 2 3 4 5 6 7 8 9 10 →